REGL ETF Analysis: ProShares S&P MidCap 400 | BATS
Small Value | BATS, USA | Market Cap: 1.816m USD | 12M Return: 13.8% | US74347B6801 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.02M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) is a US-listed fund that tracks an index composed of S&P MidCap 400 companies with at least 15 consecutive years of dividend increases. Under normal market conditions, it invests at least 80% of its total assets in index components or instruments with similar economic characteristics, using financial instruments selected by ProShare Advisors to replicate index performance. The ETF falls into the small-cap value category based on its market capitalization of approximately $1.75 billion USD and has been trading since its 2015 listing.
The Dividend Aristocrats designation is a well-known market concept referring to companies that have consistently raised their dividends over a sustained period, and mid-cap stocks typically represent medium-sized publicly traded companies by market value. Dividend-focused ETFs like this one are commonly used by income-oriented investors seeking exposure to companies with established capital return track records.
- Mid-cap dividend aristocrat segment gains as quality premium expands
- Rising interest rates pressure high-dividend ETF valuations
- Sustained dividend growth from S&P MidCap 400 holdings drives total return
As of August 21, 2026, the stock is trading at USD 93.98 with a total of 45,341 shares traded. Over the past week, the price has changed by -1.65%, over one month by +1.09%, over three months by +7.01% and over the past year by +13.84%.
Current recommended Stop Loss: 91.50 (which is 2.6% or 2.5 ATR below the current price).
ProShares S&P MidCap 400 has no consensus analysts rating.